GENETIC PREDICTORS OF SEVERITY AND EFFICACY OF COVID-19 PHARMACOTHERAPY
The pandemic of the novel coronavirus infection 2019 (COVID-19) has changed many aspects of our lives and initiated numerous studies aimed at finding the factors that determine different courses of this infectious disease. The studies aimed at finding predictors of the severe course of this novel co...
Saved in:
Main Authors: | I. N. Shishimorov (Author), O, V. Magnitskaya (Author), Yu. V. Ponomareva (Author) |
---|---|
Format: | Book |
Published: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ECONOMIC ASSESSMENT OF MAGNESIUM DEFICIENCY CORRECTION FOR BASIC THERAPY EFFICACY OF UNCONTROLLED ASTHMA IN CHILDREN
by: V. I. Petrov, et al.
Published: (2015) -
PHARMACOTHERAPY POSSIBILITIES OF CARDIOVASCULAR AUTONOMOUS NEUROPATHY IN CHILDREN WITH TYPE 1 DIABETES MELLITUS AT THE PRECLINICAL STAGE
by: N. V. Malyuzhinskaya, et al.
Published: (2022) -
MECHANISMS OF CYTOKINE STORM DEVELOPMENT IN COVID-19 AND NEW POTENTIAL TARGETS OF PHARMACOTHERAPY
by: V. I. Petrov, et al.
Published: (2021) -
Laboratory and genetic predictors for severe COVID-19 infection
by: Tanya Kadiyska, et al.
Published: (2024) -
CLINICAL AND ECONOMIC ANALYSIS OF GENETICALLY ENGINEERED BIOLOGICS CONSUMPTION BY PATIENTS WITH COVID-19
by: V. I. Petrov, et al.
Published: (2022)